Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C11H11Cl2N3O5S |
| Molecular Weight | 368.193 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
| Stereo Comments | Assumed racemic; |
SHOW SMILES / InChI
SMILES
CS(=O)(=O)N(CCO)C1=C2NC(=O)C(=O)NC2=CC(Cl)=C1Cl
InChI
InChIKey=BGJHUMNCODFLCH-UHFFFAOYSA-N
InChI=1S/C11H11Cl2N3O5S/c1-22(20,21)16(2-3-17)9-7(13)5(12)4-6-8(9)15-11(19)10(18)14-6/h4,17H,2-3H2,1H3,(H,14,18)(H,15,19)
| Molecular Formula | C11H11Cl2N3O5S |
| Molecular Weight | 368.193 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:33:46 GMT 2023
by
admin
on
Sat Dec 16 11:33:46 GMT 2023
|
| Record UNII |
VB7NS5O57X
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
VB7NS5O57X
Created by
admin on Sat Dec 16 11:33:46 GMT 2023 , Edited by admin on Sat Dec 16 11:33:46 GMT 2023
|
PRIMARY | |||
|
9842188
Created by
admin on Sat Dec 16 11:33:46 GMT 2023 , Edited by admin on Sat Dec 16 11:33:46 GMT 2023
|
PRIMARY | |||
|
UK-212189
Created by
admin on Sat Dec 16 11:33:46 GMT 2023 , Edited by admin on Sat Dec 16 11:33:46 GMT 2023
|
PRIMARY | Quinoxaline derivs. useful in therapy; Authors: Stobie, A., Mowbray, C.E., Fray, M.J. (Pfizer Inc.); Source: US 5852016, WO 9609295 |